Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Sponsor: UCB Biopharma SRL
Summary
The purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA, also known as radiographic axSpa (r-axSpA)) including ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (nr-axSpa).
Official title: A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Study Participants With Active Axial Spondyloarthritis, Ankylosing Spondylitis, and Nonradiographic Axial Spondyloarthritis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
508
Start Date
2020-06-16
Completion Date
2026-08-07
Last Updated
2026-03-27
Healthy Volunteers
No
Interventions
Bimekizumab
Subjects will receive bimekizumab at prespecified time-points.
Locations (75)
As0014 50062
Glendale, Arizona, United States
As0014 50052
Phoenix, Arizona, United States
As0014 50060
Upland, California, United States
As0014 50059
Ormond Beach, Florida, United States
As0014 50056
Sarasota, Florida, United States
As0014 50015
Hagerstown, Maryland, United States
As0014 50016
St Louis, Missouri, United States
As0014 50055
Portland, Oregon, United States
As0014 50020
Duncansville, Pennsylvania, United States
As0014 50057
Dallas, Texas, United States
As0014 40004
Brussels, Belgium
As0014 40003
Genk, Belgium
As0014 40001
Ghent, Belgium
As0014 40006
Plovdiv, Bulgaria
As0014 40007
Plovdiv, Bulgaria
As0014 40005
Sofia, Bulgaria
As0014 40008
Sofia, Bulgaria
As0014 20040
Beijing, China
As0014 20021
Chengdu, China
As0014 20019
Guangzhou, China
As0014 20034
Hefei, China
As0014 20024
Nanjing, China
As0014 20018
Shanghai, China
As0014 20020
Shanghai, China
As0014 20026
Shanghai, China
As0014 20025
Wenzhou, China
As0014 40011
Brno, Czechia
As0014 40009
Pardubice, Czechia
As0014 40013
Prague, Czechia
As0014 40014
Prague, Czechia
As0014 40015
Prague, Czechia
As0014 40016
Prague, Czechia
As0014 40010
Uherské Hradiště, Czechia
As0014 40012
Zlín, Czechia
As0014 40018
Boulogne-Billancourt, France
As0014 40022
Limoges, France
As0014 40025
Berlin, Germany
As0014 40029
Hamburg, Germany
As0014 40024
Hanover, Germany
As0014 40027
Herne, Germany
As0014 40078
Leipzig, Germany
As0014 40026
Ratingen, Germany
As0014 40032
Debrecen, Hungary
As0014 40031
Szeged, Hungary
As0014 40033
Székesfehérvár, Hungary
As0014 20035
Bunkyō City, Japan
As0014 20030
Chūōku, Japan
As0014 20039
Iruma-gun, Japan
As0014 20036
Kawachi-Nagano, Japan
As0014 20045
Kita-gun, Japan
As0014 20065
Kitakyushu, Japan
As0014 20037
Osaka, Japan
As0014 20084
Saga, Japan
As0014 20048
Saitama, Japan
As0014 20031
Sapporo, Japan
As0014 20032
Suita, Japan
As0014 40034
Amsterdam, Netherlands
As0014 40038
Elblag, Poland
As0014 40042
Krakow, Poland
As0014 40037
Lublin, Poland
As0014 40044
Poznan, Poland
As0014 40040
Torun, Poland
As0014 40041
Warsaw, Poland
As0014 40039
Wroclaw, Poland
As0014 40043
Wroclaw, Poland
As0014 40045
A Coruña, Spain
As0014 40046
Córdoba, Spain
As0014 40048
Santiago de Compostela, Spain
As0014 40049
Seville, Spain
As0014 40052
Ankara, Turkey (Türkiye)
As0014 40053
Ankara, Turkey (Türkiye)
As0014 40050
Istanbul, Turkey (Türkiye)
As0014 40057
Edinburgh, United Kingdom
As0014 40056
Leeds, United Kingdom
As0014 40055
Norwich, United Kingdom